Vagus Nerve Stimulation Market to Surge at 11.4% CAGR till 2026; Growing Adoption of Electrical Stimulation Techniques for Neurological Conditions to Boost the Market

The global vagus nerve stimulation (VNS) market size is projected to reach USD 1,194.4 million by 2026 on account of rising application of VNS technique in treating a variety of conditions including heart disorders. This information is contained in the latest Fortune Business Insights™ report, titled “Vagus Nerve Stimulation (VNS) Market Size, Share & Industry Analysis, By Type (Invasive, and Non-invasive {nVNS}), By Application (Epilepsy, Treatment Resistant Depression (TRD), and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026”. As per the findings of the report, the market value stood at USD 505.2 million in 2018 and is anticipated to register a CAGR of 11.4% from 2019 to 2026.

LivaNova’s Pivotal Study Testing the Efficacy of VNS-based ART Treatment Takes Off

One of the leading vagus nerve stimulation market trends is the intense zeal with which market players are undertaking clinical studies to investigate the effectiveness of novel VNS treatments. LivaNova launched its pivotal study in September 2018 on these lines exactly. Named Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction (ANTHEM-HFrEF), the study is being conducted to test the efficacy of the company’s VITARIA System which uses VNS to deliver the Autonomic Regulation Therapy (ART). The treatment option, which got the CE Mark approval in 2015, is engineered to treat patients who undergo frequent episodes of heart failure. If successful, the study would prove that VNS therapy can be applied in treating or managing diverse health conditions, including those chronic and acute in nature.

To Get the detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/vagus-nerve-stimulation-therapy-market-101184

Penetration of Non-invasive VNS Devices to Aid Market Growth

Vagus Nerve Stimulation (VNS) is a treatment procedure that involves stimulating the vagus nerve through electrical impulses. The conventional VNS method is invasive in nature as it requires the implantation of the VNS device on the vagus nerve which necessitates a surgical incision. While these devices still remain widely popular among patients and doctors, the demand for non-invasive VNS devices is steadily rising. Industry leaders are, therefore, shifting their focus towards developing non- or minimally-invasive VNS devices to meet the market demand. More importantly, these new-age devices are receiving the necessary regulatory support. For instance, electroCore’s gammaCore non-invasive VNS device got the US FDA’s nod in 2019. Such approvals are also encouraging other players to innovate, thereby accelerating the vagus nerve stimulation market growth in the coming years.

Dedicated Focus on Portfolio Expansion to Spur Competition

According to the vagus nerve stimulation market report, competition in this market insulated and monopolized due to the domineering presence of a few big players. With adequate financial might, these companies are able to diversify their product offerings by investing in research and development to come out with innovative solutions.

Industry Development

• November 2017: The US Food and Drug Administration (FDA) green lit the NSS-2 Bridge, the electric stimulation device, developed by Innovative Health Solutions to counter the withdrawal symptoms of opioid withdrawal. The device is placed behind the ear and sends electrical pulses to specific cranial nerves.

Further Report Findings:

• North America is foreseen to lead the vagus nerve stimulation market share during the forecast period as the region’s market size stood at USD 244.7 million in 2018. Factors enabling the dominance of the region include access to advanced VNS therapies, rising rate of diagnosis and treatment of neurological conditions, and supportive reimbursement policies.


• Increasing investment in healthcare infrastructure is expected to brighten the growth prospects of the market in the Middle East, Africa, and Latin America.


• Clinically proven efficacy of VNS technique in treating epilepsy will aid in giving a substantial lead to the epilepsy segment, the VNS market analysis says.


• The invasive devices segment is set to lead the market in terms of type owing to the widespread availability of invasive and implantable VNS devices.

Global Vagus Nerve Stimulation (VNS) Market ScopeTable of Segmentation